Identification of CDCP1 as a hypoxia-inducible factor 2 (HIF-2 ) target gene that is associated with survival in clear cell renal cell carcinoma patients
Name
Emerling-2013-Identification of CD.pdf
Size
665.96 KB
Format
Adobe PDF
Checksum (MD5)
89777b768abd73145915b9a5ef6e3242
Author(s)
Emerling, B. M.
Benes, Cyril H.
Poulogiannis, G.
Courtney, K.
Liu, H.
Choo-Wing, R.
Bellinger, Gary
Tsukazawa, K. S.
Brown, V.
Signoretti, S.
Date Issued
February 2013
Journal
Proceedings of the National Academy of Sciences
Publisher
National Academy of Sciences (U.S.)
Citation
Emerling, B. M., C. H. Benes, G. Poulogiannis, E. L. Bell, K. Courtney, H. Liu, R. Choo-Wing, et al. “Identification of CDCP1 as a hypoxia-inducible factor 2 (HIF-2 ) target gene that is associated with survival in clear cell renal cell carcinoma patients.” Proceedings of the National Academy of Sciences 110, no. 9 (February 26, 2013): 3483-3488.
Version
Final published version
Abstract
CUB domain-containing protein 1 (CDCP1) is a transmembrane protein that is highly expressed in stem cells and frequently overexpressed and tyrosine-phosphorylated in cancer. CDCP1 promotes cancer cell metastasis. However, the mechanisms that regulate CDCP1 are not well-defined. Here we show that hypoxia induces CDCP1 expression and tyrosine phosphorylation in hypoxia-inducible factor (HIF)-2α–, but not HIF-1α–, dependent fashion. shRNA knockdown of CDCP1 impairs cancer cell migration under hypoxic conditions, whereas overexpression of HIF-2α promotes the growth of tumor xenografts in association with enhanced CDCP1 expression and tyrosine phosphorylation. Immunohistochemistry analysis of tissue microarray samples from tumors of patients with clear cell renal cell carcinoma shows that increased CDCP1 expression correlates with decreased overall survival. Together, these data support a critical role for CDCP1 as a unique HIF-2α target gene involved in the regulation of cancer metastasis, and suggest that CDCP1 is a biomarker and potential therapeutic target for metastatic cancers.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Paul F. Glenn Center for Biology of Aging Research (Massachusetts Institute of Technology)
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1073/pnas.1222435110
